MDGS
Income statement / Annual
Last year (2023), Medigus Ltd.'s total revenue was $91.72 M,
a decrease of 0.15% from the previous year.
In 2023, Medigus Ltd.'s net income was -$16.03 M.
See Medigus Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$91.72 M |
$91.86 M |
$10.12 M |
$531,000.00 |
$273,000.00 |
$436,000.00 |
$467,000.00 |
$549,000.00 |
$618,906.00 |
$684,141.00 |
| Cost of Revenue |
$79.88 M
|
$77.41 M
|
$5.32 M
|
$1.03 M
|
$455,000.00
|
$607,000.00
|
$516,000.00
|
$176,000.00
|
$274,870.00
|
$321,526.00
|
| Gross Profit |
$11.84 M
|
$14.45 M
|
$4.80 M
|
-$503,000.00
|
-$182,000.00
|
-$171,000.00
|
-$49,000.00
|
$373,000.00
|
$344,036.00
|
$362,615.00
|
| Gross Profit Ratio |
0.13
|
0.16
|
0.48
|
-0.95
|
-0.67
|
-0.39
|
-0.1
|
0.68
|
0.56
|
0.53
|
| Research and Development Expenses |
$5.89 M
|
$4.85 M
|
$1.05 M
|
$997,000.00
|
$609,000.00
|
$1.81 M
|
$2.21 M
|
$3.66 M
|
$4.36 M
|
$3.70 M
|
| General & Administrative Expenses |
$12.11 M
|
$14.17 M
|
$9.96 M
|
$5.49 M
|
$13.18 M
|
$3.34 M
|
$3.01 M
|
$3.68 M
|
$2.83 M
|
$2.11 M
|
| Selling & Marketing Expenses |
$4.66 M
|
$4.01 M
|
$1.99 M
|
$471,000.00
|
$326,000.00
|
$1.35 M
|
$846,000.00
|
$2.13 M
|
$2.66 M
|
$2.15 M
|
| Selling, General & Administrative Expenses |
$16.77 M
|
$18.18 M
|
$11.95 M
|
$5.97 M
|
$13.51 M
|
$4.69 M
|
$3.85 M
|
$5.81 M
|
$5.49 M
|
$4.25 M
|
| Other Expenses |
$329,000.00
|
$45,000.00
|
$494,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$0.00
|
$0.00
|
| Operating Expenses |
$22.66 M
|
$23.03 M
|
$13.00 M
|
$6.96 M
|
$14.11 M
|
$6.50 M
|
$6.06 M
|
$9.46 M
|
$9.85 M
|
$7.95 M
|
| Cost And Expenses |
$102.54 M
|
$100.44 M
|
$18.31 M
|
$8.00 M
|
$14.57 M
|
$7.11 M
|
$6.58 M
|
$9.64 M
|
$10.12 M
|
$8.27 M
|
| Interest Income |
$0.00
|
$0.00
|
$347,000.00
|
$205,000.00
|
$99,000.00
|
$0.00
|
$71,000.00
|
$99,000.00
|
$0.00
|
$30,817.00
|
| Interest Expense |
$1.53 M
|
$2.31 M
|
$347,000.00
|
$0.00
|
$0.00
|
$0.00
|
$17,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$3.98 M
|
$1.80 M
|
-$14.03 M
|
-$503,000.00
|
-$35,000.00
|
$42,000.00
|
$77,000.00
|
$99,000.00
|
$121,168.00
|
$75,502.00
|
| EBITDA |
-$12.84 M |
-$11.99 M |
-$22.23 M |
-$7.89 M |
-$14.46 M |
-$6.78 M |
-$5.96 M |
-$9.02 M |
-$9.49 M |
-$8.68 M |
| EBITDA Ratio |
-0.14
|
-0.13
|
-2.2
|
-14.85
|
-52.95
|
-15.55
|
-12.76
|
-16.42
|
-15.33
|
-12.69
|
| Operating Income Ratio |
-0.25
|
-0.15
|
-0.81
|
-13.91
|
-52.82
|
-15.3
|
-13.08
|
-16.56
|
-15.35
|
-10.74
|
| Total Other Income/Expenses Net |
$1.52 M
|
-$1.52 M
|
$12.35 M
|
$624,000.00
|
-$9.98 M
|
$94,000.00
|
$3.56 M
|
$112,000.00
|
$88,378.00
|
$992,562.00
|
| Income Before Tax |
-$21.81 M
|
-$10.10 M
|
$4.15 M
|
-$6.84 M
|
-$14.18 M
|
-$6.58 M
|
-$2.55 M
|
-$8.98 M
|
-$9.41 M
|
-$5.81 M
|
| Income Before Tax Ratio |
-0.24
|
-0.11
|
0.41
|
-12.88
|
-51.94
|
-15.09
|
-5.46
|
-16.36
|
-15.21
|
-8.49
|
| Income Tax Expense |
-$74,000.00
|
$111,000.00
|
$105,000.00
|
$9,000.00
|
-$1,000.00
|
$20,000.00
|
-$7,000.00
|
$28,000.00
|
$67,628.00
|
$3,338.53
|
| Net Income |
-$16.03 M
|
-$10.21 M
|
$4.05 M
|
-$6.85 M
|
-$14.18 M
|
-$6.60 M
|
-$2.55 M
|
-$9.01 M
|
-$9.48 M
|
-$5.81 M
|
| Net Income Ratio |
-0.17
|
-0.11
|
0.4
|
-12.9
|
-51.93
|
-15.13
|
-5.45
|
-16.41
|
-15.32
|
-8.49
|
| EPS |
-9.5 |
-6.28 |
0.13 |
-0.77 |
-2.72 |
-48 |
-60.74 |
-785.47 |
0 |
0 |
| EPS Diluted |
-9.5 |
-6.28 |
0.13 |
-0.77 |
-2.72 |
-47.14 |
-69.88 |
-786 |
0 |
0 |
| Weighted Average Shares Out |
$1.69 M
|
$1.63 M
|
$30.71 M
|
$8.90 M
|
$5.21 M
|
$137,458.00
|
$36,418.00
|
$11,459.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$1.69 M
|
$1.63 M
|
$30.71 M
|
$8.90 M
|
$5.21 M
|
$139,960.00
|
$43,230.00
|
$11,467.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
